Nome |
# |
The effectiveness of desensitization versus rechallenge treatment in HIV-positive patients with previous hypersensitivity to TMP-SMX: A randomized multicentric study, file e39773b8-bf63-35a3-e053-3a05fe0aac26
|
452
|
Feasibility and physiological effects of prone positioning in non-intubated patients with acute respiratory failure due to COVID-19 (PRON-COVID): a prospective cohort study, file e39773b6-c7c4-35a3-e053-3a05fe0aac26
|
218
|
Acetylator phenotype prevalence in HIV-infected patients without previous trimethoprim-sulfamethoxazole hypersensitivity, file e39773b8-b92a-35a3-e053-3a05fe0aac26
|
162
|
Long-term durability of tenofovir-based antiretroviral therapy In relation to the Co-administration of other drug classes in routine clinical practice, file e39773b3-7d7f-35a3-e053-3a05fe0aac26
|
127
|
Il linfoma di Hodgkin nei soggetti con infezione da HIV, file e39773b6-a635-35a3-e053-3a05fe0aac26
|
111
|
Switch da Tenofovir disoproxil fumarato (TDF) a Tenofovir alafenamide (TAF) e aumento del colesterolo: impatto sulla valutazione del rischio cardiovascolare, file e39773b6-a9eb-35a3-e053-3a05fe0aac26
|
108
|
Lipid profile improvement in virologically suppressed HIV-1-infected patients switched to dolutegravir/abacavir/lamivudine: data from the SCOLTA project, file e39773b6-9b66-35a3-e053-3a05fe0aac26
|
101
|
Discontinuation of initial antiretroviral therapy in clinical practice: Moving toward individualized therapy, file e39773b3-76a3-35a3-e053-3a05fe0aac26
|
97
|
Pillars of long-term antiretroviral therapy success, file 76107b51-a286-4b34-bbf3-d5b0ba3de280
|
95
|
Durability, safety, and efficacy of rilpivirine in clinical practice: results from the SCOLTA project, file e39773b6-7f27-35a3-e053-3a05fe0aac26
|
94
|
The Effect of Switching from Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide (TAF) on Liver Enzymes, Glucose, and Lipid Profile, file e39773b7-1fcd-35a3-e053-3a05fe0aac26
|
94
|
Bone Safety of Dolutegravir-Containing Regimens in People Living with HIV: Results from a Real-World Cohort, file e39773b6-c980-35a3-e053-3a05fe0aac26
|
93
|
Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors: Results from a large observational cohort study (SCOLTA), file e39773b6-b4d7-35a3-e053-3a05fe0aac26
|
91
|
Positioning of darunavir/cobicistat-containing antiretroviral regimens in real life: Results from a large multicentre observational prospective cohort (SCOLTA), file e39773b6-ae6d-35a3-e053-3a05fe0aac26
|
87
|
Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy, file e39773b6-7f25-35a3-e053-3a05fe0aac26
|
84
|
Characteristics and Clinical Implications of Carbapenemase-Producing Klebsiella pneumoniae Colonization and Infection, Italy, file e39773b7-6b62-35a3-e053-3a05fe0aac26
|
83
|
A prospective randomized trial on abacavir/ lamivudine plus darunavir/ritonavir or raltegravir in HIV-positive drug-naïve patients with CD4<200 cells/uL (the PRADAR study), file e39773b6-a3af-35a3-e053-3a05fe0aac26
|
82
|
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial, file e39773b7-2481-35a3-e053-3a05fe0aac26
|
81
|
Alexithymia Predicts Carotid Atherosclerosis, Vascular Events, and All-Cause Mortality in Human Immunodeficiency Virus-Infected Patients: An Italian Multisite Prospective Cohort Study, file e39773b6-7ca1-35a3-e053-3a05fe0aac26
|
75
|
HIV clinical pathway: A new approach to combine guidelines and sustainability of anti-retroviral treatment in Italy, file e39773b6-db28-35a3-e053-3a05fe0aac26
|
75
|
The high volume of patients admitted during the SARS-CoV-2 pandemic has an independent harmful impact on in-hospital mortality from COVID-19, file e39773b7-a668-35a3-e053-3a05fe0aac26
|
75
|
Chronic care models per il management della infezione da HIV: una opportunità per migliorare le pratiche di cura, file e39773b6-a9e9-35a3-e053-3a05fe0aac26
|
74
|
Clusterization of co-morbidities and multi-morbidities among persons living with HIV: A cross-sectional study, file e39773b6-a7ac-35a3-e053-3a05fe0aac26
|
73
|
Disentangling the Association of Hydroxychloroquine Treatment with Mortality in Covid-19 Hospitalized Patients through Hierarchical Clustering, file e39773b7-4e01-35a3-e053-3a05fe0aac26
|
73
|
Safety and tolerability of Elvitegravir/ Cobicistat/Emtricitabine/Tenofovir Disoproxil fumarate in a real life setting: Data from surveillance cohort long-term toxicity antiretrovirals/antivirals (SCOLTA) project, file e39773b6-eeac-35a3-e053-3a05fe0aac26
|
64
|
Prospective Study on Incidence, Risk Factors and Outcome of Recurrent Clostridioides difficile Infections, file e39773b7-a2af-35a3-e053-3a05fe0aac26
|
62
|
New Highly Active Antiretroviral drugs and generic drugs for the treatment of HIV infection: A budget impact analysis on the Italian National Health Service (Lombardy Region, Northern Italy), file e39773b7-126e-35a3-e053-3a05fe0aac26
|
61
|
Smoking habits in HIV-infected people compared with the general population in Italy: a cross-sectional study, file e39773b6-cd0f-35a3-e053-3a05fe0aac26
|
60
|
Dysmetabolism, Diabetes and Clinical Outcomes in Patients Cured of Chronic Hepatitis C: A Real-Life Cohort Study, file e39773b8-1347-35a3-e053-3a05fe0aac26
|
60
|
Association Between Sex Hormone Levels and Clinical Outcomes in Patients With COVID-19 Admitted to Hospital: An Observational, Retrospective, Cohort Study, file e39773b8-b117-35a3-e053-3a05fe0aac26
|
52
|
Caratteristiche di una coorte di pazienti con co-infezione HIV/HCV: i dati dell’Ambulatorio di Malattie Infettive dell’Ospedale San Gerardo di Monza, file e39773b6-6315-35a3-e053-3a05fe0aac26
|
50
|
Streptococcus agalactiae infective endocarditis complicated by multiple mycotic hepatic aneurysms and massive splenic infarction: A case report, file e39773b7-9115-35a3-e053-3a05fe0aac26
|
46
|
Steroids in severe COVID-19 patients: A retrospective analysis on the first pandemics in Lombardy, file e39773b7-cd34-35a3-e053-3a05fe0aac26
|
46
|
Tocilizumab in patients hospitalised with COVID-19 pneumonia: Efficacy, safety, viral clearance, and antibody response from a randomised controlled trial (COVACTA), file e39773b8-b7f6-35a3-e053-3a05fe0aac26
|
46
|
Cost-Utility Analysis of Lopinavir/Ritonavir versus Atazanavir + Ritonavir Administered as First-Line Therapy for the Treatment of HIV Infection in Italy: From Randomised Trial to Real World, file e39773b7-60ba-35a3-e053-3a05fe0aac26
|
45
|
Lopinavir/Ritonavir and Darunavir/Cobicistat in Hospitalized COVID-19 Patients: Findings From the Multicenter Italian CORIST Study, file e39773b7-70c4-35a3-e053-3a05fe0aac26
|
44
|
Patient-Reported Symptoms and Sequelae 12 Months After COVID-19 in Hospitalized Adults: A Multicenter Long-Term Follow-Up Study, file e39773b8-d31c-35a3-e053-3a05fe0aac26
|
44
|
Cost of human immunodeficiency virus infection in Italy, 2007-2009: Effective and expensive, are the new drugs worthwhile?, file e39773b7-70da-35a3-e053-3a05fe0aac26
|
41
|
Timing of antiretroviral therapy initiation after a first AIDS-defining event: Temporal changes in clinical attitudes in the ICONA cohort, file e39773b7-807f-35a3-e053-3a05fe0aac26
|
37
|
HIV and SARS-CoV-2 Co-Infection: What are the Risks?, file e39773b7-e7c2-35a3-e053-3a05fe0aac26
|
37
|
Effect of High-Titer Convalescent Plasma on Progression to Severe Respiratory Failure or Death in Hospitalized Patients With COVID-19 Pneumonia: A Randomized Clinical Trial, file e39773b8-1345-35a3-e053-3a05fe0aac26
|
34
|
Gestione clinica della malaria nel paziente HIV positivo, file e39773b8-4cf7-35a3-e053-3a05fe0aac26
|
33
|
Causes of HIV Treatment Interruption during the Last 20 Years: A Multi-Cohort Real-Life Study, file b3cc98db-abb2-4c56-8107-69117ff34130
|
32
|
Long pentraxin 3 (PTX3) levels predict death, intubation and thrombotic events among hospitalized patients with COVID-19, file 74117a64-f2f4-44ff-b03f-212723ef870e
|
31
|
Prevalence of HDV infection in people living with HIV: Data from a multicenter Italian cohort, file bff55125-7b05-4190-8b1f-fd72ad598982
|
31
|
miRNA Expression Profiling in Subcutaneous Adipose Tissue of Monozygotic Twins Discordant for HIV Infection: Validation of Differentially Expressed miRNA and Bioinformatic Analysis, file e39773b8-d31a-35a3-e053-3a05fe0aac26
|
31
|
HIV disease treatment in the era of HAART, file e39773b9-1fda-35a3-e053-3a05fe0aac26
|
29
|
Disuguaglianze sanitarie e malattie infettive:molto ancora da fare, file e39773b7-9486-35a3-e053-3a05fe0aac26
|
25
|
Incident Atrial Fibrillation and In-Hospital Mortality in SARS-CoV-2 Patients, file 46d25b79-25cd-4c65-a97d-797b74b0199d
|
23
|
Reversibility of Central Nervous System Adverse Events in Course of Art, file e39773b9-50c4-35a3-e053-3a05fe0aac26
|
23
|
Efficacy and Safety of Reparixin in Patients with Severe COVID-19 Pneumonia: A Phase 3, Randomized, Double-Blind Placebo-Controlled Study, file 0f1e4e7e-4f05-4c89-b10f-acf1da1a7799
|
22
|
Association Between Sex Hormone Levels and Clinical Outcomes in Patients With COVID-19 Admitted to Hospital: An Observational, Retrospective, Cohort Study, file e39773b8-6825-35a3-e053-3a05fe0aac26
|
22
|
Il trattamento della epatite C nel paziente HIV-positivo: le peculiarità di un grande successo
Treatment of hepatitis C in HIV-positive patients: some features of a great success, file a57b7073-ccb4-42f0-b775-d3f39b8cf58b
|
21
|
Infezione disseminata da Mycobacterium avium complex con batteriemia persistente in un paziente AIDS-presenter
[Disseminated Mycobacterium avium complex infection with persistent bacteremia in an AIDS-presenter patient], file 724a35b7-52ce-4369-bd16-56ad9dad1bfc
|
19
|
SLAM Project - Second-Level Diagnostic Assessment: Multidisciplinary approach to HIV Patients, file e39773b6-9990-35a3-e053-3a05fe0aac26
|
19
|
What is the impact of SARS-CoV-2 pandemic on antimicrobial stewardship programs (ASPs)? The results of a survey among a regional network of infectious disease centres, file 73257af6-3230-4539-96ae-82e35d7b025b
|
15
|
Lipids and Transaminase in Antiretroviral-Treatment-Experienced People Living with HIV, Switching to a Doravirine-Based vs. a Rilpivirine-Based Regimen: Data from a Real-Life Setting, file 87db0f05-f0ef-4cab-a06d-d7ed4cc588ac
|
15
|
Infezione da HIV e gestione delle malattie cardiovascolari: molta strada ancora da fare
HIV infection and management of cardiovascular disease: still a long way to go, file e36830b0-1ba0-4e8e-ae48-9837af72fce5
|
15
|
A multidisciplinary approach to screen the post-COVID-19 conditions, file 48fca19b-8f93-48f8-99de-27ee2272eb8c
|
13
|
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial (Journal of Translational Medicine, (2020), 18, 1, (405), 10.1186/s12967-020-02573-9), file 5f2a15c9-1e2f-4afc-ba28-2914cebb26e6
|
13
|
Trajectories of CD4+/CD8+ T-Cells Ratio 96 Weeks after Switching to Dolutegravir-Based Two-Drug Regimens: Results from a Multicenter Prospective Cohort Study, file 89807ad8-c2fa-4923-b52d-c274477f1dea
|
13
|
Ruolo delle strutture ambulatoriali extra-ospedaliere per pazienti con COVID-19: l’esperienza dell’Hotspot COVID di Monza.
Role of outpatient facilities for patients with COVID-19: the experience of the COVID Hotspot in Monza., file 98c04fe6-57e4-448a-b622-89365b6a8203
|
13
|
Incidence and Microbiology of Hospital-Acquired Infections in COVID-19 Patients between the First and the Second Outbreak of the SARS-CoV-2 Pandemic: A Retrospective, Observational Study, file 1eaf1ea2-e168-4a58-a0e7-a0dc57006475
|
12
|
Real-life comparison of mortality in patients with SARS-CoV-2 infection at risk for clinical progression treated with molnupiravir or nirmatrelvir plus ritonavir during the Omicron era in Italy: a nationwide, cohort study, file 2a2edf7c-2db0-4c04-a571-47e7b5cc9f83
|
12
|
Early prone positioning does not improve the outcome of patients with mild pneumonia due to SARS-CoV-2: results from an open-label, randomised controlled trial (the EPCoT Study), file 81fc7bee-87d7-4433-bce2-01d387dbc420
|
12
|
Response to first-line ritonavir-boosted protease inhibitors (PI/r)-based regimens in HIV positive patients presenting to care with low CD4 counts: Data from the Icona Foundation Cohort, file b30b7605-2d7e-4e0e-8431-bc7c01da14d0
|
12
|
Malassorbimento intestinale della terapia antiretrovirale in un paziente affetto da AIDS e micobatteriosi atipica disseminata, file e39773b7-b982-35a3-e053-3a05fe0aac26
|
12
|
Evidence gaps on weight gain in people living with HIV: a scoping review to define a research agenda, file 052c9c64-1a07-4903-af70-bb8d61acd176
|
11
|
Lipids and transaminase elevations in ARV-experienced PLWH switching to a doravirine-based regimen from rilpivirine or other regimens, file 1fbf5bc5-26cf-44c3-953d-ab3a5ab109b8
|
11
|
Fattori associati con il ricovero ospedaliero per COVID-19 in 80 pazienti HIV-positivi italiani.
Factors associated with hospital admission for COVID-19 in 80 Italian HIV patients., file 18c8de8b-f40c-44ff-bd45-15bfd1e9f43a
|
10
|
Growing old with antiretroviral therapy or elderly people in antiretroviral therapy: two different profiles of comorbidity?, file 7c15f46f-e689-4220-a83e-f5d3332cb042
|
10
|
GRAd-COV2 vaccine provides potent and durable humoral and cellular immunity to SARS-CoV-2 in randomized placebo-controlled phase 2 trial, file 5bec21d4-5fd4-4342-b065-f80d411f8a3b
|
9
|
Real-life safety of Emtricitabine/Tenofovir Alafenamide/Bictegravir, file eff31b41-eb49-43c0-9f71-4cee895886b7
|
7
|
One Health and Global Health: il nuovo lessico delle malattie infettive
[One Health and Global Health: the new lexicon of infectious diseases], file 10238db9-eee9-41a9-8d04-ef55142c687c
|
6
|
Symptomatic neurocognitive impairmentassociated to CNS viral escape in an HIV-1 infected patient: a case report., file 185f3567-46e7-4cfe-980d-e7f1abc3d154
|
6
|
Mpox Virus in the Pharynx of Men Having Sex with Men: A Case Series, file 2e874e80-d1ea-40dc-ad57-4149e99faedc
|
5
|
Effect of a quality improvement program on compliance to the sepsis bundle in non-ICU patients: a multicenter prospective before and after cohort study, file 81be17ae-6952-4b70-84b6-9aa6b1d85a6a
|
5
|
Perché una nuova rivista scientifica?
Why a new scientific journal?, file a0613de6-200d-47c9-b35f-1620cbad5777
|
4
|
Invecchiare con la terapia antiretrovirale o essere anziani in terapia antiretrovirale: due profili di comorbidità differenti?, file 8696ec37-5ca2-47d5-8b9e-0adffa073a55
|
3
|
The effect of frailty on in-hospital and medium-term mortality of patients with COronaVIrus Disease-19: the FRACOVID study, file e39773b8-3180-35a3-e053-3a05fe0aac26
|
3
|
Predictors of protease inhibitor-associated adverse events, file 732df33b-1c47-4408-bfcf-212ec31b092c
|
2
|
Relazioni pericolose: la co-infezione HIV/HPV
HIV and HPV coinfection: a dangerous liaison, file c451d4d5-1709-41f4-8c37-63b89d0a4c34
|
2
|
It is time to rethink the approach to cardiovascular risk in people with HIV., file dab4ea5b-f993-466c-91e0-7c89d4f99773
|
2
|
Delirium in Patients with SARS‐CoV‐2 Infection: A Multicenter Study, file e39773b7-13cf-35a3-e053-3a05fe0aac26
|
1
|
Totale |
4.149 |